Presents a letter to the editor about a randomized double blind controlled trial of 2% ketoconazole cream versus 0.05% clobetasol 17-butyrate cream in seborrhoeic dermatitis published in the January 1998 issue of the Journal of the European Academy of Dermatology and Venereology.